PreciseDx

📍 New York, United States🗓 Founded 2020👥 24 employees💰 Last funded Dec 2021
Medical and Diagnostic Laboratories🌐 precisedx.ai
Website LinkedIn
PreciseDx® is innovating oncology diagnostics, leveraging Artificial Intelligence (AI) for revolutionary, morphology-driven, disease analysis. Combining AI with our patented Morphology Feature Array® (MFA), PreciseDx provides access to unmatched disease insights and accurate, actionable intelligence for more comprehensive decision-making throughout the cancer care continuum.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in PreciseDx?
PreciseDx has 2 investors on record on gritt.io, including 2 early-stage backers.
When did PreciseDx last raise funding?
The most recent investment in PreciseDx recorded on gritt.io was in December 2021.
When was PreciseDx founded?
PreciseDx was founded in 2020.
What industry is PreciseDx in?
PreciseDx operates in Medical and Diagnostic Laboratories. Find similar Medical and Diagnostic Laboratories investors on gritt.io.
Where is PreciseDx based?
PreciseDx is headquartered in New York, United States.